Study shows financial engineering could make life-saving drugs more available, affordable
At a time when breakthrough therapies for certain cancers, hepatitis C, and rare diseases remain out of reach for many patients due to their prohibitive cost, new research by Dana-Farber Cancer Institute and MIT Sloan School ...
Feb 24, 2016
0
50